Hematology, Transfusion and Cell Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.5 | Q3 | 27.2% | 0.370 | Q3 | 50.6% |
| 2024 | 1.6 | Q3 | 33.3% | 0.360 | Q3 | 51.5% |
| 2023 | 1.8 | Q3 | 25.8% | 0.376 | Q3 | 55.7% |
| 2022 | 2.1 | 25.4% | 0.323 | Q3 | 53.0% | |
| 2021 | — | 25.2% | 0.396 | Q3 | 60.0% | |
| 2020 | — | — | 0.412 | Q3 | 60.4% | |
| 2019 | — | — | 0.324 | Q3 | 54.8% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2531-1379
ISSN
2531-1387
country
coverage
2018-2026
